GlucoTrack Inc. (GCTK)
0.08
-0.04 (-34.43%)
At close: Jan 15, 2025, 10:59 AM
Company Description
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally.
It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
GlucoTrack Inc.
| Country | IL |
| IPO Date | Apr 25, 2013 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Paul V. Goode Ph.D. |
Contact Details
Address: 8 Ariel Sharon Street Or Yehuda, IL | |
| Website | https://www.glucotrack.com |
Stock Details
| Ticker Symbol | GCTK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001506983 |
| CUSIP Number | 45824Q507 |
| ISIN Number | US45824Q5071 |
| Employer ID | 98-0668934 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Paul V. Goode Ph.D. | Chief Executive Officer, President & Director |
| James S. Cardwell | Chief Financial Officer |
| Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board |
| David Malka BA | Co-Founder |
| Drinda Benjamin | Vice President of Marketing |
| James P. Thrower Ph.D. | Vice President of Engineering |
| Mark Tapsak Ph.D. | Vice President of Technology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 14, 2025 | 8-K/A | [Amend] Current Report |
| Jan 13, 2025 | 8-K | Current Report |
| Jan 08, 2025 | 8-K | Current Report |
| Jan 07, 2025 | 8-K | Current Report |
| Jan 03, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Dec 31, 2024 | 8-K | Current Report |
| Dec 17, 2024 | 424B5 | Filing |
| Dec 17, 2024 | 8-K | Current Report |
| Dec 06, 2024 | DEF 14A | Filing |
| Dec 03, 2024 | 8-K | Current Report |